Chief Financial Officer
Gustaf is a business-oriented economist with broad financial and operational experience. He is responsible for the company’s financial management and reporting and will play an important role in the company’s continued efforts to develop its investor relations. Gustaf comes must recently from the position of CEO of Elanders Sverige AB, a subsidiary of Elanders AB, listed on Nasdaq Stockholm’s Mid Cap list, and was before that the CFO for the same company. Prior to Elanders, Gustaf worked for Deloitte and Arthur Andersen as an accountant for 17 years and as an authorized accountant for 11 years. During his time as auditor, Gustaf gained broad and profound knowledge in accounting and financial reporting, focusing on IFRS, for larger Swedish and international companies. Gustaf holds a Master of Science in Economics and International Accounting and Auditing from the School of Economics from the University of Gothenburg.
Gustaf joined Isofol in 2017.
Position: Chief Financial Officer
Holdings*: 8 000 shares, 176 300 warrants**
Phone: +(46) 709 168 302
** Isofol Medical AB (publ) warrent program 2018 series 2018/2022 and 2018/2023 . For more information and terms read more under Corporate Governance.